{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-013897","form_type":"8-K","ticker":"VYGR","cik":"0001640266","company_name":"Voyager Therapeutics, Inc.","filed_at":"2026-02-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.721601+00:00","generated_at":"2026-05-16T03:02:47.221636+00:00","sec_items":["5.02","8.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Chief Medical Officer Toby Ferguson resigns; CEO Sandrock takes over clinical leadership","bullets":["Toby Ferguson, M.D., Ph.D., resigned as CMO effective Feb 20, 2026, to pursue a new opportunity.","Resignation is not due to any disagreement with the company.","CEO Alfred W. Sandrock, Jr., M.D., Ph.D., will assume interim oversight of clinical development programs."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-013897","json":"https://secwatch.observer/filing/0001104659-26-013897.json","markdown":"https://secwatch.observer/filing/0001104659-26-013897.md","text":"https://secwatch.observer/filing/0001104659-26-013897.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926013897/0001104659-26-013897-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926013897/tm266042d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T03:02:47.221636+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}